• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物相关溶出度试验在预测双氯芬酸钠口服缓释微丸剂型体内性能中的应用。

Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.

作者信息

Jantratid Ekarat, De Maio Vincenzo, Ronda Emanuela, Mattavelli Valentina, Vertzoni Maria, Dressman Jennifer B

机构信息

Institute of Pharmaceutical Technology, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.

出版信息

Eur J Pharm Sci. 2009 Jun 28;37(3-4):434-41. doi: 10.1016/j.ejps.2009.03.015. Epub 2009 Apr 5.

DOI:10.1016/j.ejps.2009.03.015
PMID:19491035
Abstract

In vitro biorelevant dissolution tests enabling the prediction of in vivo performance of an oral modified-release (MR) dosage form were developed in this study. In vitro dissolution of MR diclofenac sodium pellets containing 100mg active ingredient was evaluated under simulated pre- and postprandial conditions using USP Apparatus 3 (reciprocating cylinder, Bio-Dis) and 4 (flow-through cell) and results compared with compendial methods using USP Apparatus 1 (basket) and 2 (paddle). In vivo, the effects of food on the absorption of diclofenac sodium from the pellet dosage form were investigated by administering the product to 16 healthy volunteers pre- and postprandially in a crossover-design study. The in vitro results were compared with the in vivo data by means of Level A in vitro-in vivo correlation (IVIVC) and Weibull distribution analysis. The compendial dissolution tests were not able to predict food effects. The biorelevant dissolution tests predicted correctly that the release (and hence absorption) of diclofenac sodium would be slower in the fed state than in the fasted state. No significant differences in extent of absorption due to changes in extent of release were predicted or observed. The results demonstrate good correlations between in vitro drug release and in vivo drug absorption in both pre- and postprandial states using the biorelevant dissolution test methods.

摘要

本研究开发了体外生物相关性溶出试验,以预测口服缓释(MR)剂型的体内性能。使用美国药典装置3(往复圆筒,Bio-Dis)和装置4(流通池),在模拟的餐前和餐后条件下,对含有100mg活性成分的双氯芬酸钠MR微丸的体外溶出度进行了评估,并将结果与使用美国药典装置1(篮法)和装置2(桨法)的药典方法进行了比较。在体内,通过在交叉设计研究中对16名健康志愿者在餐前和餐后给予该产品,研究了食物对双氯芬酸钠从微丸剂型中吸收的影响。通过A级体外-体内相关性(IVIVC)和威布尔分布分析,将体外结果与体内数据进行了比较。药典溶出试验无法预测食物的影响。生物相关性溶出试验正确预测,双氯芬酸钠在进食状态下的释放(以及因此的吸收)将比禁食状态下更慢。未预测到或观察到由于释放程度变化导致的吸收程度有显著差异。结果表明,使用生物相关性溶出试验方法,在餐前和餐后状态下,体外药物释放与体内药物吸收之间均具有良好的相关性。

相似文献

1
Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.生物相关溶出度试验在预测双氯芬酸钠口服缓释微丸剂型体内性能中的应用。
Eur J Pharm Sci. 2009 Jun 28;37(3-4):434-41. doi: 10.1016/j.ejps.2009.03.015. Epub 2009 Apr 5.
2
Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.使用模拟体内物理应力的溶出度试验装置,可以预测双氯芬酸缓释片的不规则吸收曲线。
Eur J Pharm Biopharm. 2008 Oct;70(2):421-8. doi: 10.1016/j.ejpb.2008.05.029. Epub 2008 Jun 7.
3
Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.双氯芬酸钠口服缓释制剂在比格犬体内外的比较评价
Pharmazie. 2009 Oct;64(10):648-52.
4
Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.预测人体口服米氮平和纳米阿瑞匹坦制剂的体内吸收和食物效应。
Eur J Pharm Biopharm. 2010 Sep;76(1):95-104. doi: 10.1016/j.ejpb.2010.05.009. Epub 2010 Jun 1.
5
Designing biorelevant dissolution tests for lipid formulations: case example--lipid suspension of RZ-50.设计脂质制剂的生物相关性溶出度试验:实例——RZ-50脂质混悬液
Eur J Pharm Biopharm. 2008 Jun;69(2):776-85. doi: 10.1016/j.ejpb.2007.12.010. Epub 2007 Dec 23.
6
Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.双氯芬酸钠两种缓释制剂(扶他林与英纷)的生物利用度和药代动力学特性:食物对英纷生物利用度的影响
Int J Clin Pharmacol Ther. 1996 Dec;34(12):564-70.
7
Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.基于生物相关溶解试验结合生理基于药代动力学模型预测塞来昔布的食物对吸收的影响。
Eur J Pharm Biopharm. 2009 Sep;73(1):107-14. doi: 10.1016/j.ejpb.2009.05.009. Epub 2009 May 22.
8
Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.采用建模与模拟方法结合生物相关性溶出试验预测多单元(微丸)剂型的口服药代动力学特征:双氯芬酸钠实例
Eur J Pharm Biopharm. 2014 Jul;87(2):236-43. doi: 10.1016/j.ejpb.2014.01.007. Epub 2014 Jan 23.
9
The role of individual gastric emptying of pellets in the prediction of diclofenac in vivo dissolution.个体微丸胃排空在预测双氯芬酸体内溶出度中的作用。
J Control Release. 2013 Mar 28;166(3):286-93. doi: 10.1016/j.jconrel.2012.12.032. Epub 2013 Jan 8.
10
Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.双氯芬酸-磷酸可待因组合经口服和直肠给药后的药代动力学及药物输入特征
Arzneimittelforschung. 1996 Jan;46(1):57-63.

引用本文的文献

1
OxDc-A0: an oral gastro-tolerant oxalate decarboxylase for treating secondary hyperoxaluria.OxDc-A0:一种用于治疗继发性高草酸尿症的口服耐胃肠草酸脱羧酶。
Urolithiasis. 2025 Mar 5;53(1):47. doi: 10.1007/s00240-025-01698-0.
2
Establishment of Biopredictive Dissolution and Bioequivalence Safe Space Using the Physiologically Based Biopharmaceutics Modeling for Tacrolimus Extended-Release Capsules.使用基于生理的生物药剂学模型建立他克莫司缓释胶囊的生物预测溶出度和生物等效性安全空间。
AAPS PharmSciTech. 2024 Dec 17;26(1):13. doi: 10.1208/s12249-024-03006-2.
3
Effects of Glass Bead Size on Dissolution Profiles in Flow-through Dissolution Systems (USP 4).
玻璃珠粒径对流动溶出系统(USP4)中溶出曲线的影响。
AAPS PharmSciTech. 2024 Oct 22;25(8):251. doi: 10.1208/s12249-024-02972-x.
4
PhysioCell - a Novel, Bio-relevant Dissolution Apparatus: Hydrodynamic Conditions and Factors Influencing the Dissolution Dynamics.PhysioCell - 一种新型的、与生理相关的溶解装置:影响溶解动力学的流体动力学条件和因素。
AAPS PharmSciTech. 2023 Feb 14;24(2):65. doi: 10.1208/s12249-022-02494-4.
5
release studies of furosemide reference tablets: influence of agitation rate, USP apparatus, and dissolution media.呋塞米参比片的释放度研究:搅拌速率、美国药典装置及溶出介质的影响
ADMET DMPK. 2020 Jun 29;8(4):411-423. doi: 10.5599/admet.801. eCollection 2020.
6
In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications.用于评估结肠靶向药物产品的体外方法及其应用的行业观点。
Pharmaceutics. 2022 Jan 26;14(2):291. doi: 10.3390/pharmaceutics14020291.
7
Design of Oral Sustained-Release Pellets by Modeling and Simulation Approach to Improve Compliance for Repurposing Sobrerol.通过建模与仿真方法设计口服缓释微丸以提高索布瑞醇重新利用的依从性
Pharmaceutics. 2022 Jan 11;14(1):167. doi: 10.3390/pharmaceutics14010167.
8
Quantification of Fluid Volume and Distribution in the Paediatric Colon via Magnetic Resonance Imaging.通过磁共振成像对小儿结肠内液体容量及分布进行定量分析。
Pharmaceutics. 2021 Oct 19;13(10):1729. doi: 10.3390/pharmaceutics13101729.
9
Development of cryptotanshinone-loaded pellets for angina chronotherapy: / prediction and evaluation.用于心绞痛时辰治疗的隐丹参酮载药丸的研制:预测与评价。
Asian J Pharm Sci. 2018 Jul;13(4):310-316. doi: 10.1016/j.ajps.2018.02.009. Epub 2018 Mar 12.
10
Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations.生物制药评估和口服缓释制剂的 CMC 方面。
AAPS J. 2017 Sep;19(5):1348-1358. doi: 10.1208/s12248-017-0112-6. Epub 2017 Jul 5.